HEADER IMMUNE SYSTEM 01-AUG-22 8ALX TITLE STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGRAMMED CELL DEATH 1 LIGAND 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HPD-L1,B7 HOMOLOG 1,B7-H1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: 3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.]PYRAZOLE, COMPND 8 AMINOMETHYLAMIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CD274, B7H1, PDCD1L1, PDCD1LG1, PDL1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS PD-L1, IMMUNOONCOLOGY, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR I.RODRIGUEZ,P.GRUDNIK,T.HOLAK,K.MAGIERA-MULARZ REVDAT 2 20-SEP-23 8ALX 1 JRNL REVDAT 1 16-AUG-23 8ALX 0 JRNL AUTH I.RODRIGUEZ,J.KOCIK-KROL,L.SKALNIAK,B.MUSIELAK,A.WISNIEWSKA, JRNL AUTH 2 A.CIESIOLKIEWICZ,L.BERLICKI,J.PLEWKA,P.GRUDNIK,M.STEC, JRNL AUTH 3 M.SIEDLAR,T.A.HOLAK,K.MAGIERA-MULARZ JRNL TITL STRUCTURAL AND BIOLOGICAL CHARACTERIZATION OF PAC65, A JRNL TITL 2 MACROCYCLIC PEPTIDE THAT BLOCKS PD-L1 WITH EQUIVALENT JRNL TITL 3 POTENCY TO THE FDA-APPROVED ANTIBODIES. JRNL REF MOL CANCER V. 22 150 2023 JRNL REFN ISSN 1476-4598 JRNL PMID 37679783 JRNL DOI 10.1186/S12943-023-01853-4 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.15.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.71 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 55356 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.118 REMARK 3 R VALUE (WORKING SET) : 0.117 REMARK 3 FREE R VALUE : 0.136 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2968 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 1.1290 - 1.1000 0.85 3512 176 0.1720 0.1820 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 SOLVENT RADIUS : 1.40 REMARK 3 SHRINKAGE RADIUS : 0.70 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.016 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.08000 REMARK 3 B22 (A**2) : 0.84000 REMARK 3 B33 (A**2) : -0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 8ALX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-AUG-22. REMARK 100 THE DEPOSITION ID IS D_1292124573. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-FEB-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58363 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 45.070 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.16 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.29900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5C3T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.4 M SODIUM ACETATE TRIHYDRATE; 0.1 M REMARK 280 SODIUM CACODYLATE PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.29550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 39.29550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 28.17250 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.73650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 28.17250 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.73650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 39.29550 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 28.17250 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 32.73650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 39.29550 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 28.17250 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 32.73650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 18 REMARK 465 PHE A 19 REMARK 465 ALA A 135 REMARK 465 ALA A 136 REMARK 465 ALA A 137 REMARK 465 LEU A 138 REMARK 465 GLU A 139 REMARK 465 HIS A 140 REMARK 465 HIS A 141 REMARK 465 HIS A 142 REMARK 465 HIS A 143 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 NH2 B 16 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 N TYR B 1 OZ1 CCS B 14 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 40 96.48 -160.50 REMARK 500 GLU A 45 -141.08 -91.88 REMARK 500 GLU A 45 -144.44 -91.88 REMARK 500 GLN A 83 -11.78 77.10 REMARK 500 TYR A 118 91.77 -163.34 REMARK 500 REMARK 500 REMARK: NULL DBREF 8ALX A 18 134 UNP Q9NZQ7 PD1L1_HUMAN 18 134 DBREF 8ALX B 1 16 PDB 8ALX 8ALX 1 16 SEQADV 8ALX ALA A 135 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX ALA A 136 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX ALA A 137 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX LEU A 138 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX GLU A 139 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 140 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 141 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 142 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 143 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 144 UNP Q9NZQ7 EXPRESSION TAG SEQADV 8ALX HIS A 145 UNP Q9NZQ7 EXPRESSION TAG SEQRES 1 A 128 ALA PHE THR VAL THR VAL PRO LYS ASP LEU TYR VAL VAL SEQRES 2 A 128 GLU TYR GLY SER ASN MET THR ILE GLU CYS LYS PHE PRO SEQRES 3 A 128 VAL GLU LYS GLN LEU ASP LEU ALA ALA LEU ILE VAL TYR SEQRES 4 A 128 TRP GLU MET GLU ASP LYS ASN ILE ILE GLN PHE VAL HIS SEQRES 5 A 128 GLY GLU GLU ASP LEU LYS VAL GLN HIS SER SER TYR ARG SEQRES 6 A 128 GLN ARG ALA ARG LEU LEU LYS ASP GLN LEU SER LEU GLY SEQRES 7 A 128 ASN ALA ALA LEU GLN ILE THR ASP VAL LYS LEU GLN ASP SEQRES 8 A 128 ALA GLY VAL TYR ARG CYS MET ILE SER TYR GLY GLY ALA SEQRES 9 A 128 ASP TYR LYS ARG ILE THR VAL LYS VAL ASN ALA PRO TYR SEQRES 10 A 128 ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 16 TYR MAA ASN PRO DPP LEU HYP TRP DAB V6W 9KK 9KK LEU SEQRES 2 B 16 CCS GLY NH2 HET MAA B 2 6 HET DPP B 5 6 HET HYP B 7 8 HET DAB B 9 7 HET V6W B 10 18 HET 9KK B 11 9 HET 9KK B 12 9 HET CCS B 14 9 HET ACT A 401 4 HET GOL A 402 6 HET ACT A 403 4 HET ACT A 404 4 HET GOL A 405 6 HETNAM MAA N-METHYL-L-ALANINE HETNAM DPP DIAMINOPROPANOIC ACID HETNAM HYP 4-HYDROXYPROLINE HETNAM DAB 2,4-DIAMINOBUTYRIC ACID HETNAM V6W NE-ACETYL-L-TRYPTOPHAN HETNAM 9KK N-METHYL NORLEUCINE HETNAM CCS CARBOXYMETHYLATED CYSTEINE HETNAM ACT ACETATE ION HETNAM GOL GLYCEROL HETSYN HYP HYDROXYPROLINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 MAA C4 H9 N O2 FORMUL 2 DPP C3 H8 N2 O2 FORMUL 2 HYP C5 H9 N O3 FORMUL 2 DAB C4 H10 N2 O2 FORMUL 2 V6W C13 H13 N2 O4 1- FORMUL 2 9KK 2(C7 H15 N O2) FORMUL 2 CCS C5 H9 N O4 S FORMUL 3 ACT 3(C2 H3 O2 1-) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 8 HOH *162(H2 O) HELIX 1 AA1 ASP A 49 ALA A 52 5 4 HELIX 2 AA2 ASP A 73 GLN A 77 5 5 HELIX 3 AA3 HIS A 78 ARG A 82 5 5 HELIX 4 AA4 LEU A 88 SER A 93 1 6 HELIX 5 AA5 LYS A 105 ALA A 109 5 5 SHEET 1 AA1 5 LEU A 27 GLU A 31 0 SHEET 2 AA1 5 ALA A 121 ASN A 131 1 O LYS A 129 N TYR A 28 SHEET 3 AA1 5 GLY A 110 SER A 117 -1 N TYR A 112 O ILE A 126 SHEET 4 AA1 5 ILE A 54 MET A 59 -1 N GLU A 58 O ARG A 113 SHEET 5 AA1 5 LYS A 62 VAL A 68 -1 O PHE A 67 N VAL A 55 SHEET 1 AA2 3 MET A 36 ILE A 38 0 SHEET 2 AA2 3 LEU A 99 ILE A 101 -1 O ILE A 101 N MET A 36 SHEET 3 AA2 3 ALA A 85 LEU A 87 -1 N ARG A 86 O GLN A 100 SHEET 1 AA3 2 TRP B 8 DAB B 9 0 SHEET 2 AA3 2 LEU B 13 CCS B 14 -1 O LEU B 13 N DAB B 9 SSBOND 1 CYS A 40 CYS A 114 1555 1555 2.02 LINK C TYR B 1 N MAA B 2 1555 1555 1.34 LINK N TYR B 1 CE CCS B 14 1555 1555 1.21 LINK C MAA B 2 N ASN B 3 1555 1555 1.37 LINK C PRO B 4 N DPP B 5 1555 1555 1.33 LINK C DPP B 5 N LEU B 6 1555 1555 1.33 LINK C LEU B 6 N HYP B 7 1555 1555 1.34 LINK C HYP B 7 N TRP B 8 1555 1555 1.33 LINK C TRP B 8 N DAB B 9 1555 1555 1.33 LINK C DAB B 9 N V6W B 10 1555 1555 1.36 LINK C V6W B 10 N 9KK B 11 1555 1555 1.39 LINK C 9KK B 11 N 9KK B 12 1555 1555 1.40 LINK C 9KK B 12 N LEU B 13 1555 1555 1.37 LINK C LEU B 13 N CCS B 14 1555 1555 1.34 LINK C CCS B 14 N GLY B 15 1555 1555 1.34 CISPEP 1 TYR B 1 MAA B 2 0 10.09 CISPEP 2 V6W B 10 9KK B 11 0 -2.11 CRYST1 56.345 65.473 78.591 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017748 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015273 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012724 0.00000